Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
Kent DM, Ruthazer R, Griffith JL, Beshansky JR, Concannon TW, Aversano T, Grines CL, Zalenski RJ, Selker HP. Kent DM, et al. Among authors: aversano t. Am J Cardiol. 2008 Mar 15;101(6):790-5. doi: 10.1016/j.amjcard.2007.10.050. Epub 2008 Jan 28. Am J Cardiol. 2008. PMID: 18328842 Clinical Trial.
Development of systems of care for ST-elevation myocardial infarction patients: the non-percutaneous coronary intervention-capable (ST-elevation myocardial infarction referral) hospital perspective.
Ellrodt G, Sadwin LB, Aversano T, Brodie B, O'Brien PK, Gray R, Hiratzka LF, Larson D. Ellrodt G, et al. Among authors: aversano t. Circulation. 2007 Jul 10;116(2):e49-54. doi: 10.1161/CIRCULATIONAHA.107.184048. Epub 2007 May 30. Circulation. 2007. PMID: 17538040 No abstract available.
Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.
Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, Forman SA; Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Aversano T, et al. Among authors: aversano lt. JAMA. 2002 Apr 17;287(15):1943-51. doi: 10.1001/jama.287.15.1943. JAMA. 2002. PMID: 11960536 Clinical Trial.
Distance, delay, and discontent.
Aversano T. Aversano T. Circ Cardiovasc Interv. 2014 Dec;7(6):739-40. doi: 10.1161/CIRCINTERVENTIONS.114.002158. Circ Cardiovasc Interv. 2014. PMID: 25516758 No abstract available.
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators.
Mark DB, Talley JD, Topol EJ, Bowman L, Lam LC, Anderson KM, Jollis JG, Cleman MW, Lee KL, Aversano T, Untereker WJ, Davidson-Ray L, Califf RM. Mark DB, et al. Among authors: aversano t. Circulation. 1996 Aug 15;94(4):629-35. doi: 10.1161/01.cir.94.4.629. Circulation. 1996. PMID: 8772681 Clinical Trial.
47 results